| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Galecto, Inc. | Director | Stock Option (right to buy) | 18,000 | 14 Jun 2023 | Direct | ||
| Fusion Pharmaceuticals Inc. | Director | Stock Option (Right to Buy) | 17,000 | 14 Jun 2023 | Direct | ||
| NextCure, Inc. | Director | Stock Option (Right to Buy) | 14,250 | 22 Jun 2023 | Direct |